Renaissance Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.14M	Buy	329,057 +76,772	+30%	+$1.67M	0.28%	87
2025 Q1	$6.12M	Buy	252,285 +49,525	+24%	+$1.2M	0.27%	81
2024 Q4	$4.23M	Buy	+202,760	New	+$4.23M	0.18%	105